Suchergebnisse - "Hindi, Nadia"

PubPharm (82)

1

Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients

enthalten in: Cytokine | 2024

von Carrillo-García, J. | Lacerenza, S. | Hindi, N. | +13

2

Management of patients with rare adult solid cancers : objectives and evaluation of European reference networks (ERN) EURACAN

enthalten in: The Lancet regional health. Europe | 2024

von Blay, J. | Casali, P. | Ray-Coquard, I. | +25

3

Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma

enthalten in: Therapeutic advances in medical oncology | 2024

von Martin-Broto, J. | Olarte-García, A. | Fernandéz-Rodríguez, R. | +14

4

Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain

enthalten in: Therapeutic advances in medical oncology | 2024

von Carrillo-García, J. | Lacerenza, S. | Hindi, N. | +13

5

Antiangiogenics in Malignant Granular Cell Tumors : Review of the Literature

enthalten in: Cancers | 2023

von Torrado, C. | Camaño, M. | Hindi, N. | +6

6

Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A

enthalten in: Signal transduction and targeted therapy | 2023

von Martin-Broto, J. | Martinez-Garcia, J. | Moura, D. | +16

7

Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas

enthalten in: Cancers | 2023

von Attia, S. | Villalobos, V. | Hindi, N. | +7

8

REGISTRI : Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

enthalten in: Molecular cancer | 2023

von Martin-Broto, J. | Valverde, C. | Hindi, N. | +24

9

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

enthalten in: Molecular cancer | 2023

von Martin-Broto, J. | Valverde, C. | Hindi, N. | +24

10

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

enthalten in: Molecular cancer | 2023

von Martin-Broto, J. | Valverde, C. | Hindi, N. | +24

1
2
3
4
5
6
7
8
9
Nächster »
[9]